DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Transcatheter aortic valve replacement (TAVR) Market - Global Industry Analysis, Size, Share, Trends and Forecast, 2014-2022" report to their offering.
The market for TAVR is expected to reach around USD 6.5 billion by 2022, growing at a CAGR of 21.3% during the forecast period of 2016e to 2022f.
However, there are certain restraining factors which could hamper the growth of this market, which includes, high costs associated with the LAVD implantation compared to other therapies available for CVD diseases.
Some of the key driving factors attributing to the growth of this market include increasing number of patients with cardiovascular diseases such as hypertension, heart failures and coronary artery diseases. In addition, increasing adoption of minimally invasive procedures over traditional surgical open heart procedures, reduction in hospital stays, low risk of infection, minimal blood loss are further propelling the market.
The company profile section include detailed analysis of some of the key players such as
- Boston Scientific Corp.
- Bracco SpA
- Direct Flow medical Inc.
- Edwards Lifesciences Corp.
- JenaValve Technology Inc.
- Medtronic plc
- Meril Life Sciences Pvt. Ltd.
- St. Jude Medical Inc.
- Transcatheter Technologies GmbH
For more information about this report visit http://www.researchandmarkets.com/research/g2mxgr/transcatheter